{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:17:43Z","timestamp":1783919863422,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Growing evidence indicates a potential association between the gut microbiome and psoriasis. Nevertheless, the precise nature of these associations and whether they constitute causal relationships remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A rigorous bidirectional two-sample Mendelian randomization study was undertaken to establish a putative causal link between gut microbiota and psoriasis. We drew upon publicly available datasets containing summary statistics from GWAS to accomplish this. Utilizing various analytical techniques, including inverse variance weighting, MR-Egger, weighted median, weighted model, and MR-PRESSO, we sought to validate the putative causal association between gut microbiota and psoriasis. A reverse Mendelian randomization analysis was conducted to further investigate the relationship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After conducting a forward Mendelian randomization analysis, a causal relationship was established between 19 gut microbiota and psoriasis. Furthermore, the reverse MR study revealed causality between psoriasis and 13 gut microbiota. Notably, no substantial heterogeneity of instrumental variables or horizontal pleiotropy was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This research suggests a potential genetic association and causal nexus between gut microorganisms and psoriasis, indicating potential implications for the clinical management and therapy of psoriasis. Additional observational studies with a larger population sample size and animal model experiments are imperative to fully elucidate this association\u2019s underlying mechanisms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1434521","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:46:54Z","timestamp":1722854814000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic insights into the gut microbiota and risk of psoriasis: a bidirectional mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Minyu","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5144\/0256-4947.2014.241","article-title":"Relationship between Helicobacter pylori infection and psoriasis.","volume":"34","author":"Azizzadeh","year":"2014","journal-title":"Ann. Saudi Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis.","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/ije\/dyt093","article-title":"Use of allele scores as instrumental variables for Mendelian randomization.","volume":"42","author":"Burgess","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.589726","article-title":"Skin and gut microbiome in psoriasis: Gaining insight into the pathophysiology of it and finding novel therapeutic strategies.","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/exd.13786","article-title":"Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients.","volume":"27","author":"Chen","year":"2018","journal-title":"Exp. Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jfda.2016.06.003","article-title":"Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice.","volume":"25","author":"Chen","year":"2017","journal-title":"J. Food Drug Anal"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22125-y","article-title":"Gut microbial composition in patients with psoriasis.","volume":"8","author":"Codo\u00f1er","year":"2018","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease?*.","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: Genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B11","article-title":"Lack of evidence of relationship between Helicobacter pylori infection and psoriasis in childhood.","volume":"137","author":"Fabrizi","year":"2001","journal-title":"Arch. Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-term prognosis in patients with psoriasis.","volume":"159","author":"Gulliver","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890250109026","article-title":"Helicobacter pylori antibodies in patients with psoriasis.","volume":"132","author":"Halasz","year":"1996","journal-title":"Arch. Dermatol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/bjd.17931","article-title":"Gut microbiota dysbiosis in a cohort of patients with psoriasis.","volume":"181","author":"Hidalgo-Cantabrana","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02166","article-title":"In Silico analysis of putrefaction pathways in bacteria and its implication in colorectal cancer.","volume":"8","author":"Kaur","year":"2017","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tim.2013.08.004","article-title":"Fusobacterium spp. and colorectal cancer: Cause or consequence?","volume":"21","author":"Keku","year":"2013","journal-title":"Trends Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.fm.2013.05.010","article-title":"Lactobacillus salivarius: Bacteriocin and probiotic activity.","volume":"36","author":"Messaoudi","year":"2013","journal-title":"Food Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence.","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00906","article-title":"The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health.","volume":"11","author":"Parker","year":"2020","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094529","article-title":"Psoriasis and gut microbiome\u2014current state of art.","volume":"22","author":"Polak","year":"2021","journal-title":"IJMS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41588-021-00991-z","article-title":"Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort.","volume":"54","author":"Qin","year":"2022","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease.","volume":"6","author":"Rau","year":"2018","journal-title":"UEG J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13582","DOI":"10.1073\/pnas.1312524110","article-title":"Metabolic niche of a prominent sulfate-reducing human gut bacterium.","volume":"110","author":"Rey","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory Bowel disease.","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41564-022-01319-1","article-title":"Hyperactive nanobacteria with host-dependent traits pervade Omnitrophota.","volume":"8","author":"Seymour","year":"2023","journal-title":"Nat. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jaad.2006.09.017","article-title":"The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study.","volume":"56","author":"Shapiro","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112713","article-title":"High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic \u03b3\u03b4 T cell IL-17 production.","volume":"42","author":"Sonomoto","year":"2023","journal-title":"Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.761978","article-title":"Involvement of gut microbiota in the development of psoriasis vulgaris.","volume":"8","author":"Sun","year":"2021","journal-title":"Front. Nutr."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051037","article-title":"Gut\u2013skin axis: Unravelling the connection between the gut microbiome and psoriasis.","volume":"10","author":"Thye","year":"2022","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8040573","article-title":"The Controversial role of human gut lachnospiraceae.","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667097","article-title":"Causal effects of gut microbiome on systemic lupus erythematosus: A two-sample Mendelian randomization study.","volume":"12","author":"Xiang","year":"2021","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.605825","article-title":"Deciphering gut microbiota dysbiosis and corresponding genetic and metabolic dysregulation in psoriasis patients using metagenomics sequencing.","volume":"11","author":"Xiao","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1083432","article-title":"The role of short-chain fatty acids in inflammatory skin diseases.","volume":"13","author":"Xiao","year":"2023","journal-title":"Front. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55100645","article-title":"Helicobacter pylori infection and psoriasis: A systematic review and meta-analysis.","volume":"55","author":"Yu","year":"2019","journal-title":"Medicina"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9424","article-title":"Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis.","volume":"6","author":"Zanvit","year":"2015","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02125-1","article-title":"Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1434521\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T10:46:58Z","timestamp":1722854818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1434521\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":38,"alternative-id":["10.3389\/fmicb.2024.1434521"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1434521","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"article-number":"1434521"}}